Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02054143Phase 4Completed
Phase 4, open-label, single-arm trial of sevoflurane, sponsored by University of Debrecen. Primary endpoint: Mean Blood Flow Velocity in the Middle Cerebral Artery at 25 months. Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02054143.